IFNA1 and End Stage Liver Disease: Based on our in vitro and in vivo data, we conclude that an increased matrix stiffness upregulates the release of OPN, which limits the IFNα- induced innate immune response by suppressing the STAT-1 and ISGs activation, thereby upregulating the expression of HBV markers and promoting the development of end-stage liver diseases (Figure 9).